| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_157f29f291ed3a4b86e2c15b71083ad0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6486
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-23015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2001-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee93f3b10cfbcaf0bfbb96e645df4941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4b01614733bca75e07651f0a20f8b65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2d93c877743108b6a4445d6390f4554 |
| publicationDate |
2001-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2404644-A1 |
| titleOfInvention |
Modulators of prorenin activity |
| abstract |
A method of selecting a substance capable of controlling the activation of prorenin with the use of, as an indication, the ability to control the activation of prorenin by an interaction between proteins in the profragment domain of prorenin; a prorenin activation controlling substance which has a function of controlling the activation of prorenin based on the interaction between proteins in the profragment domain of prorenin; and hypotensors, org an overgrowth inhibitors and arterial thickening inhibitors containing the abov e- described prorenin activation controlling substance as the active ingredient . |
| priorityDate |
2000-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |